Total mesorectal excision for the treatment of rectal cancer
Keywords:
mesorectal excision, rectal cancer, neoadjuvent chemoradiotherapyAbstract
Introduction: In the surgical treatment of rectal cancer, a clear circumferential resection margin and distal resection margin should be obtained. The aim of this study was to determine the morbidity, mortality, survival outcome, and local failure after total mesorectal excision (TME) in the surgical treatment of rectal cancer.
Methods: This retrospective study was conducted on 101 patients treated for rectal cancer using low anterior resection (LAR), abdominoperinial resection (APR), or Hartmaan’s technique. In all operative procedures, total mesorectal excisions (TMEs) were done. The patients were treated from November 2000 to April 2011 in the South Egypt Cancer Institute (SECI) of Assuit University (Egypt). Neo-adjuvant therapy was given to those patients with serosalin filtration, lymph node involvement, and sexual and urinary function impairment. Data were analyzed using IBM-SPSS version 21, and survival rates were estimated using the Kaplan-Meier method.
Results: One hundred one patients were evaluable (61 males, 40 females). Regarding the operative procedure used, it was: (APR), LAR, Hartmaan’s technique in 15.8%, 71.3%, and 12.9% of patients, respectively. Operation-related mortality during the 30 days after surgery was 3%. The operations resulted in morbidity in 25% of the patients, anastomotic site leak in 5.9% of the patients, urinary dysfynction in 9.9% of the patients, and erectile dysfunction in 15.8% of the male patients. Regarding safety margin, the median distances were distal/radial margin, 23/12 mm, distal limit 7 cm. Median lymph nodes harvest 19 nodes. Primary tumor locations were anteriorly 23.8%, laterally 13.9%, posteriorly 38.6%, and circumferential 23.8%. Protective stoma 16.8%. Primary Tumor TNM classification (T1, T2, T3, and T4; 3, 28.7, 55.4, and 12.9%, respectively). Nodes Metastases (N0, N1, and N2; 57.4, 31.7, and 10.9%, respectively). TNM staging (I, II, III, and IV; 15.8, 29.7, 46.5, and 7.9%, respectively). Chemotherapy was administered to 67.3% of the patients. Radiotherapy (short course neoadjuvant, long course neoadjuvant, and adjuvant postoperative used in 33.7, 20.8, and 19.8% of patients, respectively). Survival 5-years CSS was 73% and 5-years RFS 71%. Mean operative time was 213 minutes. The average amount of intraoperative blood loss was 344 mL.
Conclusion: Total mesorectal excision (TME) represents the gold-standard technique in rectal cancer surgery. It is safe with neoadjuvent chemoradiotherapy and provides both maximal oncological efficiency (local control and long-term survival and maintenance of a good quality of life).
References
David B. Stewart. David W. Dietz.Total Mesorectal Excision: What Are WeDoing? Clin Colon Rectal Surg
;20:190–202. doi: 10.1055/s-2007-984863, PMid: 20011200, PMCid: PMC2789502
Jae Heon Kim, Tae Il Noh, Mi Mi Oh, Jae Young Park, Jeong Gu Lee, Jun Won Um, et al. Voiding
Dysfunction after Total Mesorectal Excision in Rectal Cancer Int Neurourol J, 2011;15:166-71.
Somprakas B, Vivek SV, Shukla K. Recent advances in the management of carcinoma of the rectum
Clinical and Experimental Gastroenterology 2009:2 49–60.
Masoud R, Jan Franko, Steven A. Fassler, Steven G. Harper, Joseph H. Nejman, D. Mark Zebley.
Outcomes in Patients Treated by Laparoscopic Resection of Rectal Carcinoma After Neoadjuvant Therapy
for Rectal Cancer JSLS, 2007;11:204-7
Simunovic M, Gafni A, Levine M. Economics of Preoperative Radiotherapy With Total Mesorectal
Excision: What Can We Learn From the Dutch Experience? Journal of Clinical Oncology, 2004;22 (2):
-9. doi: 10.1200/JCO.2004.11.918, PMid: 14665616
Guillem JG, Chessin DB, Cohen AM, Jinru S, Mazumdar M, Enker W, et al. Long-term Oncologic
Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally
Advanced Rectal Cancer Annals of Surgery, 2005; 241 (5): 829-38
Allal AS, Bieri S, Pelloni A, Spataro V, Anchisi D, Ambrosetti P, et al. Sphincter-sparing surgery after
preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes
British Journal of Cancer (2000) 82(6), 1131–1137. doi: 10.1054/bjoc.1999.1052, PMid: 10735495,
PMCid: PMC2363346
Washington MK, Berlin J, Branton P, Lawrence J, Burgart, David K, et al. Protocol for the Examination of
Specimens From Patients With Primary Carcinoma of the Colon and Rectum Arch Pathol Lab Med. 2009;
(10): 1539-51.
Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal
cancer without adjuvant therapy: a word of caution. Ann Surg. 2000 Mar;231(3):345-51. PMID: 10714627,
PMCID: PMC1421005
Marr R, Birbeck K, Garvican J, Christopher PM, Nicholas J. Tiffin. The Modern Abdominoperineal
Excision, Annals of Surgery, 2005; 242 (1): 74-85
Phang PT. Total mesorectal excision: technical aspectsJ can chir, 2004; 47 (2): 130-7.
Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, et al. Local excision after
preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected
patients with T3 rectal cancer. Ann Surg Oncol. 2010;17(2):441-7. doi: 10.1245/s10434-009-0735-7 PMID:
, PMCID: PMC3076509.
Mehta PP, Griffin J, Ganta S, Rangraj M, Steichen F. Laparoscopic-assisted colon resections: long-term
results and survival. JSLS. 2005;9(2):184-8. PMID: 15984707, PMCID: PMC3015573
Koulas SG, Pappas-Gogos G, Spirou S, Roustanis E, Tsimogiannis KE, Tsirves G, Tsimoyiannis EC.
Evaluations of laparoscopic proctocolectomy versus traditional technique in patients with rectal cancer.
JSLS. 2009;13(4):564-73. doi: 10.4293/108680809X12589998404489. PMID: 20202399, PMCID:
PMC3030793
Bradley J Champagne, Rohit MakhijaMinimally invasive surgery for rectal cancer: Are we thereyet? World
J Gastroenterol 2011 February 21; 17(7): 862-866. doi: 10.3748/wjg.v17.i7.862, PMid: 21412496, PMCid:
PMC3051137
Siripong Sirikurnpiboon and Paiboon JivapaisarnpongSingle-Access Laparoscopic Rectal SurgeryIs
Technically FeasibleVolume 2013, Article ID 687134. PMid: 23577248, PMCid: PMC3615606
Bianchi PP, Petz W1, Luca F2, Biffi R3, Spinoglio G4, Montorsi M5. Laparoscopic and robotic total
mesorectal excision in the treatment of rectal cancer. Brief review and personal remarks. Front Oncol. 2014
May 6;4:98. doi: 10.3389/fonc.2014.00098. eCollection 2014. PMID: 24834429, PMCID: PMC4018567
de Lacy AM, Rattner DW, Adelsdorfer C, Tasende MM, Fernández M, Delgado S, et al. Transanal natural
orifice transluminal endoscopic surgery (NOTES) rectal resection: "down-to-up" total mesorectal excision
(TME)--short-term outcomes in the first 20 cases. Surg Endosc. 2013 Sep;27(9):3165-72. doi:
1007/s00464-013-2872-0. Epub 2013 Mar 22. PMID: 23519489
Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation
of 622 patients. Ann Surg. 2004 Aug;240(2):260-8. PMID: 15273550, PMCID: PMC1356402
Konishi T, Watanabe T, Nagawa H, Oya M, Ueno M, Kuroyanagi H, et al. Preoperative chemoradiation
and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles. World J Gastrointest
Surg. 2010 Apr 27;2(4):95-100. doi: 10.4240/wjgs.v2.i4.95. PMID: 21160857, PMCID: PMC2999227
Leong QM, Kim SH. Robot-Assisted Rectal Surgery for Malignancy: A Review of Current Literature Ann
Acad Med Singapore, 2011;40:460-6. Available from:
http://www.annals.edu.sg/pdf/40VolNo10Oct2011/V40n10p460.pdf
Floris T. J. Ferenschild &Imro Dawson &Johannes H. W. de Wilt &Eelco J. R. de Graaf &Richard P. R.
Groenendijk &Geert W. M. Tetteroo Total mesorectal excision for rectal cancer in an
unselectedpopulation: quality assessment in a low volume center Int J Colorectal Dis (2009) 24:923–929.
doi: 10.1007/s00384-009-0732-0, PMid: 19488771, PMCid: PMC2699389
Wen-long Gu1 and Sheng-wen Meta-analysis of defunctioning stoma in low anterior resection with total
mesorectal excisionfor rectal cancer: evidence based on thirteen studies Gu and Wu World Journal of
Surgical Oncology, 2015:13:9.
Grama F.A., T. Burcoæ, A. Bordea, D. Cristian Localisation.Preservation of the Autonomic Nerves in
Rectal CancerSurgery –Technical Details Chirurgia (2014) 109: 375-382.
Koh DM, Brown G, Temple L, Raja A, Toomey P, Bett N, et al. Rectal cancer: mesorectal lymph nodes at
MR imaging with USPIO versus histopathologic findings--initial observations. Radiology. 2004
Apr;231(1):91-9. Epub 2004 Feb 19. PMID: 14976266
Muhammad Shafique Sajid, Adil Ahamd, William FA Miles, Mirza Khurrum BaigSystematic review of
oncological outcomes following laparoscopic vs open total mesorectal excision World J Gastrointest
Endosc 2014 May 16; 6(5): 209-219. doi: 10.4253/wjge.v6.i5.209, PMid: 24891934, PMCid:
PMC4024494
Lisa A. Kachnic, MATheodore S. Hong, , MADavid P. Ryan.Rectal Cancer at the Crossroads: The
Dilemma of Clinically Staged T3, N0, M0 Disease Journal of Clinical Oncology, Vol 26, No 3 (January
, 2008: pp 350-351. doi: 10.1200/JCO.2007.14.6365, PMid: 18202407
Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, et al. Impact of T and N
stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004
May 15;22(10):1785-96. Epub 2004 Apr 5. PMID: 15067027
van den Brink M, Stiggelbout AM, van den Hout WB, Kievit J, Klein Kranenbarg E, Marijnen CA, et al.
Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or
without preoperative radiotherapy. J Clin Oncol. 2004 Oct 1;22(19):3958-64. PMID: 15459218
Jun-xin Wu, Yu Wang, Na Chen, Lu-chuan Chen, Peng-gang Bai and Jian-ji Pan. In the era of total
mesorectal excision: adjuvantradiotherapy may be unnecessary for pT3N0rectal cancer Wu et al. Radiation
Oncology 2014, 9:159. doi: 10.1186/1748-717X-9-159, PMid: 25052511, PMCid: PMC4223727
Morino M, Parini U, Giraudo G, Salval M, Brachet Contul R, Garrone C. Laparoscopic total mesorectal
excision: a consecutive series of 100 patients. Ann Surg. 2003 Mar;237(3):335-42. PMID: 12616116,
PMCID: PMC1514324
Valentin L. Ignatov, Nikola Y. Kolev, Anton Y. Tonev, Georgi H. Ivanov, AleksanderK. Zlatarov, Georgi
Todorov, Velian Platikanov, Krasimir D. Clinical Outcome Of Intersphincteric resection For Ultra-Low
Rectal Cancerjimab.2012181.226
Karyn B. Stitzenberg, Hanna K. Sanoff, Dolly C. Penn, Michael O. Meyers, and Joel E. Tepper Practice
Patterns and Long-Term Survival for Early-Stage Rectal Cancer. J Clin Oncol 31:4276-4282.
Szynglarewicz B, Matkowski R, Kasprzak P, Sydor D, Forgacz J, Pudelko M, et al. Sphincter-preserving
R0 total mesorectal excision with resection of internal genitalia combined with pre- or postoperative
chemoradiation for T4 rectal cancer in females, World J Gastroenterol, 2007; 13(16): 2339-43
Gong J, De-Bing Shi, Xin-Xiang Li, San-Jun Cai, Zu-Qing Guan, Ye Xu. Short-term outcomes of
laparoscopic total mesorectal excision compared to open surgery World J Gastroenterol, 2012; 18(48):
-13. doi: 10.3748/wjg.v18.i48.7308, PMid: 23326138, PMCid: PMC3544035
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
